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During the past few decades floating drug delivery systems
(FDDSs) have been developed to prolong gastric retention time
and obtain sufficient drug bioavailability [1]. To avoid unpre-
dictable time to float due to variable pH of the gastric fluid in
each subject and food in the stomach [2], sublimation tech-
nique is the new interesting approach to prepare non-
effervescent FDDSs [3]. The objective of the present study was
to develop the low-density film coated floating tablets using
sublimable substances.
To prepare low density porous core tablets, model drug (an-
hydrous theophylline), filler (e.g., microcrystalline cellulose,
HPMC), and sublimable substance (ammonium carbonate) were
mixed for 10 min prior to addition of magnesium stearate (0.5%
w/w) and Aerosil®200 (0.5% w/w). The powder mixture was
further mixed for 3 min and compressed into tablets (diam-
eter, 9.53 mm; biconvex; hardness, 9–10 kg; average tablet
weight, 300 mg) using a single punch tableting machine (Model
YH06, Yeo Heng Co., Ltd., Thailand). The tablets were incu-
bated at 70 °C for 72 h to eliminate sublimable substance.The
porous tablets were coated with Eudragit® RL 30D plasti-
cized with 20% w/w diethyl phthalate. Coating condition is as
follows: batch size, 1 kg; preheating temperature, 50 °C; pre-
heating time, 30 min; inlet temperature, 48–50 °C; outlet
temperature, 39–41 °C; atomizing air pressure, 2.5 bar; spray
rate, 5–8 mL/min.
The results exhibited that addition and increasing level of
sublimable substance increased porosity of core tablet, leading
to reduction of density and hardness of the tablet. Although
the porous core tablets could float immediately, the floating
time of the core was quite short. Therefore, the polymeric
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membrane was needed.The SEM photomicrograph of a cross-
section of film coated floating tablets demonstrates the porous
structure of the core tablet coated with Eudragit® RL30D film
(Fig. 1). The film coated floating tablets using sublimable sub-
stance could initially float due to low-density of the systems
(<1 g/cm3) and maintain floatation more than 8 h with sus-
tained drug release as required in this study. Eudragit®RL30D
coating might not only plays a role to control the drug release,
but also entrap air in the porous structure of the core tablet
and maintain low density of the system.
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Fig. 1 – Schematic and SEM photomicrograph of a cross-section of film coated floating tablets (40% w/w ammonium
carbonate, 10% w/w Eudragit® RL30D) (A) and drug release profiles (B).
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